CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for brain and central nervous system cancers, will host a Virtual Analyst & Investor Day on December 11 from 11:30 a.m. to 1 p.m. ET. The event will feature presentations by the company’s leadership team, including CEO John Climaco, Chief Medical Officer Dr. Sandra Silberman, and…
Annovis Bio (NYSE: ANVS), a leader in developing treatments for neurodegenerative diseases, was recently featured on Today’s Marketplace in an exclusive interview with Dr. Maria Maccecchini, Founder, President, and CEO. Dr. Maccecchini detailed Annovis Bio’s groundbreaking drug development targeting toxic proteins responsible for nerve cell damage in Alzheimer’s and Parkinson’s, as well as the company’s…
Thumzup Media Corp. (NASDAQ: TZUP) plans to integrate its innovative ad tech platform with X Corp. (formerly Twitter), expanding its reach to over 535 million monthly active users. This integration, expected by January 2025, complements Thumzup’s existing presence on Instagram, allowing unified campaign management, enhanced audience targeting, and user monetization through authentic brand endorsements. CEO…
McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned for opportunity as artificial intelligence is rapidly reshaping the landscape of economies around the world. “Estimates indicate that generative AI alone will triple its growth to a total market value of $1.3 trillion in the next decade… As most investors know by now, there is a surge…
Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for…
SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing innovative biological products targeting inflammation and immunology (“I&I”) and offering contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices division, released its financial results for the nine months ending Sept. 30, 2024. The announcement highlights the company’s progress in advancing its I&I-focused pipeline…
Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, provided an update on its Fullerton, California, battery operations, which focus on producing next-generation battery packs and modules domestically. This initiative supports Mullen’s commitment to zero emissions and reducing reliance on imported battery components. CEO and Chairman David Michery emphasized the company’s mission to transition to American-made…
McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the evolution of artificial intelligence (“AI”), spotlighting Geoffrey Hinton’s (“the Godfather of AI”) award of the Nobel Prize in Physics alongside John Hopfield for their groundbreaking work that triggered the development of machine learning, the science behind AI as we know…
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing transformative therapies for neurodegenerative disorders, including Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently achieved a significant milestone in its drug development process. In early October, the company held a meeting with the U.S. Food and Drug Administration (“FDA”), where it received…
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, today announced the results from two studies evaluating its groundbreaking vector-based technology. According to the announcement, the data add to the body of evidence for HeartBeam’s key clinical indications, specifically arrhythmia and heart attack…
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) was featured in a recent article by Simply Wall St. The publication describes Platinum’s ownership structure, explaining that the company is primarily owned by individual investors, who hold a 51% majority stake, granting them substantial influence over the company’s governance and management decisions. Institutional investors also…
Mullen Automotive (NASDAQ: MULN) announced that the California Air Resources Board (“CARB”) has approved Bollinger Motors’ all-electric Class 4 Bollinger B4 truck for the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (“HVIP”). Under HVIP, the Bollinger B4, priced at $158,758, qualifies for up to $60,000 in state vouchers, potentially reducing its cost to under…
NextPlat (NASDAQ: NXPL, NXPLW) announced its participation in the 2024 China International Natural Health & Nutrition Expo (“NHNE”) in Wuhan, showcasing OPKO Health Europe products, including new veterinary and animal care offerings. Supported by its in-country marketing partner, NextPlat has seen increasing demand for OPKO products in China, fueled by online and offline promotional campaigns.…
CNS Pharmaceuticals (NASDAQ: CNSP) reported Q3 2024 financial results and highlighted clinical advancements, including the ongoing potentially pivotal trial of Berubicin, a targeted chemotherapy for recurrent glioblastoma multiforme (“GBM”). Enrollment of 252 patients was completed, with primary analysis data expected in the first half of 2025. Berubicin, which crosses the blood-brain barrier, has received Fast…
Mullen Automotive (NASDAQ: MULN) announced a partnership with National Auto Fleet Group (“NAFG”) to sell its all-electric Class 4 Bollinger B4 commercial trucks to government agencies via NAFG’s Sourcewell-awarded contract. The Bollinger B4, designed with fleet and upfitter input, offers a 185-mile range, a payload of 7,394 pounds, and a robust chassis protecting its 158-kilowatt-hour…
NextPlat (NASDAQ: NXPL, NXPLW) reported Q3 2024 results reflecting the impact of its recent acquisitions, including Progressive Care and Outfitter Satellite, which contributed to consolidated revenues of $15.4 million. While healthcare revenue declined due to lower prescription reimbursement rates, e-Commerce revenue saw a 31% increase, largely from the Outfitter acquisition. The company recorded a net…